Explorer
Bharat Biotech seeks emergency use approval for Covaxin
After Pfizer and Serum Institute of India (SII), Bharat Biotech has applied for the emergency use approval for its Coronavirus vaccine, Covaxin. The Hyderabad based company has written to written to central drug regulator seeking emergency use authorization.
The vaccine has been developed by Bharat Biotech in collaboration with Indian Council of Medical Research (ICMR)
The vaccine has been developed by Bharat Biotech in collaboration with Indian Council of Medical Research (ICMR)
India
Breaking: Pune Poison Liquor Case Sparks Violence After 13 Deaths, Liquor Shop Vandalised
WILDFIRE ALERT: Forest Fires Spread Across J&K, Himachal & Uttarakhand Amid Rising Heatwave
WEATHER SHIFT: Pre-Monsoon Showers Bring Relief, IMD Warns of Below-Normal Rainfall
POLITICAL REMARK: Yogi Adityanath Warns Mafia, Defines “4 Castes” in Mau Speech
POLITICAL ATTACK: Yogi Adityanath Slams Opposition, Highlights UP Welfare Schemes in Mau Rally
View More





















